Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag added to horse ATG + cyclosporine for untreated severe aplastic anemia
2014-000363-40Phase 3Completed
- Sponsor
- European Society for Blood and Marrow Transplantation
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of eltrombopag in aplastic anemia and idiopathic aplastic anemia (2 arms), sponsored by European Society for Blood and Marrow Transplantation. Primary endpoint: Complete response rate at 3 months. Started Sep 2015; status: completed.
02
Drugs
eltrombopag
03
Conditions
aplastic anemiaidiopathic aplastic anemia
Beyond the preview
Go deeper on 2014-000363-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000363-40.